Obesity-related hypertension and its remission following gastric bypass surgery – A review of the mechanisms and predictive factors

References

• Malnick SD, Knobler H. The medical complications of obesity. QJM. 2006;99:565–579.
   PubMed Web of Science ®Google Scholar
• Uwaifo G, Arioglu E. Obesity. www.emedicine.com/med/topic1653.htm; 2006.
   Google Scholar
• Reilly JJ, Kelly J. Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: Systematic review. Int J Obes (Lond). 2011;35:891–898.
   PubMed Web of Science ®Google Scholar
• Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298:2028–2037.
   PubMed Web of Science ®Google Scholar
• Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. Obesity in adulthood and its consequences for life expectancy: A life-table analysis. Ann Intern Med. 2003;138:24–32.
   PubMed Web of Science ®Google Scholar
• Davy KP, Hall JE. Obesity and hypertension: Two epidemics or one?Am J Physiol Regul Integr Comp Physiol. 2004; 286:R803–R813.
   PubMed Web of Science ®Google Scholar
• Doll S, Paccaud F, Bovet P, Burnier M, Wietlisbach V. Body mass index, abdominal adiposity and blood pressure: Consistency of their association across developing and developed countries. Int J Obes Relat Metab Disord. 2002;26:48–57.
   PubMed Web of Science ®Google Scholar
• Garrison RJ, Kannel WB, Stokes J, 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: The Framingham Offspring Study. Prev Med. 1987;16:235–251.
   PubMed Web of Science ®Google Scholar
• Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med. 2002;162:1867–1872.
   PubMed Web of Science ®Google Scholar
• Dorresteijn JA, Visseren FL, Spiering W. Mechanisms linking obesity to hypertension. Obes Rev. 2012;13:17–26.
   PubMed Web of Science ®Google Scholar
• Jones DW, Kim JS, Andrew ME, Kim SJ, Hong YP. Body mass index and blood pressure in Korean men and women: The Korean National Blood Pressure Survey. J Hypertens. 1994;12:1433–1437.
   PubMed Web of Science ®Google Scholar
• da Silva AA, do Carmo J, Dubinion J, Hall JE. The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep. 2009;11:206–211.
   PubMedGoogle Scholar
• Masuo K, Mikami H, Ogihara T, Tuck ML. Weight gain-induced blood pressure elevation. Hypertension. 2000;35:1135–1140.
   PubMed Web of Science ®Google Scholar
• Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension. 2003; 42:878–884.
   PubMed Web of Science ®Google Scholar
• Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29:2959–2971.
   PubMed Web of Science ®Google Scholar
• Kalil GZ, Haynes WG. Sympathetic nervous system in obesity-related hypertension: Mechanisms and clinical implications. Hypertens Res. 2011;35:4–16.
   PubMedGoogle Scholar
• Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation. 1994;89:2634–2640.
   PubMed Web of Science ®Google Scholar
• Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome. J Clin Endocrinol Metab. 2005; 90:5998–6005.
   PubMed Web of Science ®Google Scholar
• Davy KP, Orr JS. Sympathetic nervous system behavior in human obesity. Neurosci Biobehav Rev. 2009;33:116–124.
   PubMed Web of Science ®Google Scholar
• Smith MM, Minson CT. Obesity and adipokines: Effects on sympathetic overactivity. J Physiol. 2012;590(Pt 8): 1787–1801.
   PubMedGoogle Scholar
• Straznicky NE, Eikelis N, Lambert EA, Esler MD. Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep. 2008;10:440–447.
   PubMed Web of Science ®Google Scholar
• Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation. 1997;96:3423–3429.
   PubMed Web of Science ®Google Scholar
• Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation. 2002; 106:2533–2536.
   PubMed Web of Science ®Google Scholar
• Grassi G, Seravalle G, Dell’Oro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension. 2000;36:538–542.
   PubMed Web of Science ®Google Scholar
• Masuo K, Mikami H, Itoh M, Ogihara T, Tuck ML. Sympathetic activity and body mass index contribute to blood pressure levels. Hypertens Res. 2000;23:303–310.
   PubMed Web of Science ®Google Scholar
• Weyer C, Pratley RE, Snitker S, Spraul M, Ravussin E, Tataranni PA. Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure. Hypertension. 2000;36:531–537.
   PubMedGoogle Scholar
• Grassi G, Dell’Oro R, Facchini A, Quarti Trevano F, Bolla GB, Mancia G. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. J Hypertens. 2004;22:2363–2369.
   PubMed Web of Science ®Google Scholar
• Ahima RS, Flier JS. Leptin. Annu Rev Physiol. 2000; 62:413–437.
   PubMed Web of Science ®Google Scholar
• Schwartz MW, Woods SC, Porte D, Jr., Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404:661–671.
   PubMed Web of Science ®Google Scholar
• Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative review: The role of leptin in human physiology: Emerging clinical applications. Ann Intern Med. 2010; 152:93–100.
   PubMed Web of Science ®Google Scholar
• Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997;100:270–278.
   PubMed Web of Science ®Google Scholar
• Shankar A, Xiao J. Positive relationship between plasma leptin level and hypertension. Hypertension. 2010;56:623–628.
   PubMedGoogle Scholar
• Rahmouni K, Morgan DA, Morgan GM, Mark AL, Haynes WG. Role of selective leptin resistance in diet-induced obesity hypertension. Diabetes. 2005;54:2012–2018.
   PubMed Web of Science ®Google Scholar
• Slominski AT. Proopiomelanocortin signaling system is operating in mast cells. J Invest Dermatol. 2006;126: 1934–1936.
   PubMed Web of Science ®Google Scholar
• Rahmouni K. Leptin-induced sympathetic nerve activation: Signaling mechanisms and cardiovascular consequences in obesity. Curr Hypertens Rev. 2011;6:104–209.
   Google Scholar
• Ouchi N, Ohishi M, Kihara S, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 2003;42:231–234.
   PubMed Web of Science ®Google Scholar
• Hug C, Lodish HF. The role of the adipocyte hormone adiponectin in cardiovascular disease. Curr Opin Pharmacol. 2005;5:129–134.
   PubMedGoogle Scholar
• Ohashi K, Kihara S, Ouchi N, et al. Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension. 2006;47:1108–1116.
   PubMed Web of Science ®Google Scholar
• Tanida M, Shen J, Horii Y, et al. Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Exp Biol Med (Maywood). 2007;232:390–397.
   PubMed Web of Science ®Google Scholar
• Wang ZV, Scherer PE. Adiponectin, cardiovascular function, and hypertension. Hypertension. 2008;51:8–14.
   PubMed Web of Science ®Google Scholar
• Tan KC, Xu A, Chow WS, et al. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab. 2004;89:765–769.
   PubMed Web of Science ®Google Scholar
• Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes. 2000; 49:1231–1238.
   PubMed Web of Science ®Google Scholar
• Lin Y, Matsumura K, Fukuhara M, Kagiyama S, Fujii K, Iida M. Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension. 2004;43: 977–982.
   PubMedGoogle Scholar
• Matsumura K, Tsuchihashi T, Fujii K, Abe I, Iida M. Central ghrelin modulates sympathetic activity in conscious rabbits. Hypertension. 2002;40:694–699.
   PubMed Web of Science ®Google Scholar
• Xu X, Jhun BS, Ha CH, Jin ZG. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology. 2008;149:4183–4192.
   PubMed Web of Science ®Google Scholar
• Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: Role of leptin and sympathetic nervous system. Am J Hypertens. 2001;14:103S–115S.
   PubMed Web of Science ®Google Scholar
• Liu J, da Silva AA, Tallam LS, Hall JE. Chronic central nervous system hyperinsulinemia and regulation of arterial pressure and food intake. J Hypertens. 2006;24: 1391–1395.
   PubMed Web of Science ®Google Scholar
• Sawicki PT, Baba T, Berger M, Starke A. Normal blood pressure in patients with insulinoma despite hyperinsulinemia and insulin resistance. J Am Soc Nephrol. 1992;3:S64–S68.
   Google Scholar
• Scherrer U, Owlya R, Trueb L. Sympathetic-nerve activity before and after resection of an insulinoma. N Engl J Med. 1996;335:1240–1242.
   PubMedGoogle Scholar
• Arnold AC, Shaltout HA, Gallagher PE, Diz DI. Leptin impairs cardiovagal baroreflex function at the level of the solitary tract nucleus. Hypertension. 2009;54:1001–1008.
   PubMed Web of Science ®Google Scholar
• Del Colle S, Milan A, Caserta M, et al. Baroreflex sensitivity is impaired in essential hypertensives with central obesity. J Hum Hypertens. 2007;21:473–478.
   PubMed Web of Science ®Google Scholar
• Lohmeier TE, Dwyer TM, Irwin ED, Rossing MA, Kieval RS. Prolonged activation of the baroreflex abolishes obesity- induced hypertension. Hypertension. 2007;49:1307–1314.
   PubMed Web of Science ®Google Scholar
• Lohmeier TE, Iliescu R, Liu B, Henegar JR, Maric-Bilkan C, Irwin ED. Systemic and renal-specific sympathoinhibition in obesity hypertension. Hypertension. 2012;59:331–338.
   PubMed Web of Science ®Google Scholar
• McCully BH, Brooks VL, Andresen MC. Diet-induced obesity severely impairs myelinated aortic baroreceptor reflex responses. Am J Physiol Heart Circ Physiol. 2012.
   Google Scholar
• Bjorntorp P, Holm G, Rosmond R, Folkow B. Hypertension and the metabolic syndrome: Closely related central origin?Blood Press. 2000;9:71–82.
   PubMed Web of Science ®Google Scholar
• Grassi G, Seravalle G, Dell’Oro R, et al. Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension. 2001;38:1316–1320.
   PubMedGoogle Scholar
• Purkayastha S, Zhang G, Cai D. Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-beta and NF-kappaB. Nat Med. 2011;17:883–887.
   PubMed Web of Science ®Google Scholar
• Engeli S, Bohnke J, Gorzelniak K, et al. Weight loss and the renin–angiotensin–aldosterone system. Hypertension. 2005; 45:356–362.
   PubMed Web of Science ®Google Scholar
• Kotchen TA. Obesity-related hypertension: Epidemiology, pathophysiology, and clinical management. Am J Hypertens. 2010;23:1170–1178.
   PubMed Web of Science ®Google Scholar
• Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol. 1992;262:E763–E778.
   PubMed Web of Science ®Google Scholar
• Matsukawa T, Gotoh E, Minamisawa K, et al. Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. Am J Physiol. 1991;261:R690–R696.
   PubMed Web of Science ®Google Scholar
• Miyajima E, Shigemasa T, Yamada Y, Tochikubo O, Ishii M. Angiotensin II blunts, while an angiotensin-converting enzyme inhibitor augments, reflex sympathetic inhibition in humans. Clin Exp Pharmacol Physiol. 1999;26:797–802.
   PubMedGoogle Scholar
• Yoshimoto M, Miki K, Fink GD, King A, Osborn JW. Chronic angiotensin II infusion causes differential responses in regional sympathetic nerve activity in rats. Hypertension. 2010;55: 644–651.
   PubMedGoogle Scholar
• Bloomfield GL, Blocher CR, Fakhry IF, Sica DA, Sugerman HJ. Elevated intra-abdominal pressure increases plasma renin activity and aldosterone levels. J Trauma. 1997;42:997–1004; discussion 1004–1005.
   PubMed Web of Science ®Google Scholar
• Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res. 1999;7: 355–362.
   PubMedGoogle Scholar
• Saiki A, Ohira M, Endo K, et al. Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus. Metabolism. 2009;58:708–713.
   PubMedGoogle Scholar
• Umemura S, Nyui N, Tamura K, et al. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens. 1997; 10:629–633.
   PubMed Web of Science ®Google Scholar
• Grossman E, Eshkol A, Rosenthal T. Diet and weight loss: Their effect on norepinephrine renin and aldosterone levels. Int J Obes. 1985;9:107–114.
   PubMedGoogle Scholar
• Sowers JR, Nyby M, Stern N, et al. Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension. 1982;4:686–691.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114:1752–1761.
   PubMed Web of Science ®Google Scholar
• Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation. 2007;116:1234–1241.
   PubMed Web of Science ®Google Scholar
• Nagae A, Fujita M, Kawarazaki H, Matsui H, Ando K, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation. 2009;119:978–986.
   PubMed Web of Science ®Google Scholar
• Schulz E, Gori T, Munzel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res. 2011;34: 665–673.
   PubMed Web of Science ®Google Scholar
• Bloomfield GL, Sugerman HJ, Blocher CR, Gehr TW, Sica DA. Chronically increased intra-abdominal pressure produces systemic hypertension in dogs. Int J Obes Relat Metab Disord. 2000;24:819–824.
   PubMed Web of Science ®Google Scholar
• Gletsu-Miller N, Hansen JM, Jones DP, et al. Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery. Obesity (Silver Spring). 2009;17:439–446.
   PubMed Web of Science ®Google Scholar
• Lambert DM, Marceau S, Forse RA. Intra-abdominal pressure in the morbidly obese. Obes Surg. 2005;15:1225–1232.
   PubMed Web of Science ®Google Scholar
• Varela JE, Hinojosa M, Nguyen N. Correlations between intra-abdominal pressure and obesity-related co-morbidities. Surg Obes Relat Dis. 2009;5:524–528.
   PubMedGoogle Scholar
• Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237:751–756; discussion 757–758.
   PubMed Web of Science ®Google Scholar
• Carson JL, Ruddy ME, Duff AE, Holmes NJ, Cody RP, Brolin RE. The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch Intern Med. 1994; 154:193–200.
   PubMedGoogle Scholar
• Jamal M, Samuel I, Heitshusen DI, Maher J. Resolution of hypertension follows surgical weight loss in patients undergoing gastric bypass surgery: A five year analysis of data. 27th Annual Meeting of the American Society for Metabolic and Bariatric Surgery. Las Vegas, NV: Surgery for Obesity and Related Diseases; 2010. p. S76.
   Google Scholar
• Czupryniak L, Strzelczyk J, Pawlowski M, Loba J. Circadian blood pressure variation in morbidly obese hypertensive patients undergoing gastric bypass surgery. Am J Hypertens. 2005;18:446–451.
   PubMedGoogle Scholar
• Hinojosa MW, Varela JE, Smith BR, Che F, Nguyen NT. Resolution of systemic hypertension after laparoscopic gastric bypass. J Gastrointest Surg. 2009;13:793–797.
   PubMed Web of Science ®Google Scholar
• Carbonell AM, Wolfe LG, Meador JG, Sugerman HJ, Kellum JM, Maher JW. Does diabetes affect weight loss after gastric bypass?Surg Obes Relat Dis. 2008;4:441–444.
   PubMedGoogle Scholar
• Ahmed AR, Rickards G, Coniglio D, et al. Laparoscopic Roux-en-Y gastric bypass and its early effect on blood pressure. Obes Surg. 2009;19:845–849.
   PubMed Web of Science ®Google Scholar
• Bueter M, Ahmed A, Ashrafian H, le Roux CW. Bariatric surgery and hypertension. Surg Obes Relat Dis. 2009;5: 615–620.
   PubMedGoogle Scholar
• Sledzinski T, Sledzinski M, Smolenski RT, Swierczynski J. Increased serum nitric oxide concentration after bariatric surgery – A potential mechanism for cardiovascular benefit. Obes Surg. 2010;20:204–210.
   PubMedGoogle Scholar
• Gokce N, Vita JA, McDonnell M, et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol. 2005;95:266–268.
   PubMed Web of Science ®Google Scholar
• Ikonomidis I, Mazarakis A, Papadopoulos C, et al. Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: A 3-year follow-up study. J Hypertens. 2007;25:439–447.
   PubMed Web of Science ®Google Scholar